Ryan Weispfenning | Vice President and Head of Investor Relations |
Geoffrey Martha | Chairman and Chief Executive Officer |
Karen Parkhill | Executive Vice President and Chief Financial Officer |
Francesca DeMartino | Vice President, Investor Relations |
Sean Salmon | Executive Vice President and President of the Diabetes Operating Unit; President, Cardiovascular Portfolio |
Bob White | Executive Vice President and President, Medical Surgical Portfolio |
Brett Wall | Executive Vice President and President, Neuroscience Portfolio |
Bob Hopkins | Bank of America Merrill Lynch |
Robert Marcus | JPMorgan |
Vijay Kumar | Evercore ISI |
Joanne Weunsch | Citigroup |
Chris Pasquale | Guggenheim Securities |
Larry Biegelsen | Wells Fargo Securities |
Rick Wise | Stifel Nicolaus |
Matthew Miksic | Credit Suisse |
Jayson Bedford | Raymond James |
Danielle Antalffy | Leerink Partners |
Steve Lichtman | Oppenheimer |
Good morning and welcome to Medtronic's Fiscal Year 2021 Fourth Quarter Earnings Video Webcast. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations.
Before we start the prepared remarks, I'm going to share with you a few details to keep in mind about today's webcast.
Joining me today are Geoff Martha, Medtronic’s Chairman and Chief Executive Officer, [Audio Gap] and Karen Parkhill, Medtronic Chief Financial Officer. Geoff and Karen will provide comments on the results of our fourth quarter and fiscal year 2021, which ended on April 30, 2021.